nodes	percent_of_prediction	percent_of_DWPC	metapath
Apixaban—ABCG2—Sulfasalazine—ankylosing spondylitis	0.146	0.151	CbGbCtD
Apixaban—CYP3A5—Sulfasalazine—ankylosing spondylitis	0.0809	0.0837	CbGbCtD
Apixaban—ABCG2—Dexamethasone—ankylosing spondylitis	0.0728	0.0754	CbGbCtD
Apixaban—ABCB1—Methylprednisolone—ankylosing spondylitis	0.0694	0.0719	CbGbCtD
Apixaban—ABCG2—Methotrexate—ankylosing spondylitis	0.0585	0.0606	CbGbCtD
Apixaban—CYP2C19—Prednisone—ankylosing spondylitis	0.0521	0.054	CbGbCtD
Apixaban—ABCB1—Betamethasone—ankylosing spondylitis	0.0452	0.0468	CbGbCtD
Apixaban—ABCB1—Prednisolone—ankylosing spondylitis	0.0446	0.0461	CbGbCtD
Apixaban—ABCB1—Prednisone—ankylosing spondylitis	0.0421	0.0436	CbGbCtD
Apixaban—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0416	0.0431	CbGbCtD
Apixaban—CYP3A5—Dexamethasone—ankylosing spondylitis	0.0404	0.0418	CbGbCtD
Apixaban—CYP2C8—Dexamethasone—ankylosing spondylitis	0.0388	0.0402	CbGbCtD
Apixaban—CYP2C19—Dexamethasone—ankylosing spondylitis	0.0326	0.0337	CbGbCtD
Apixaban—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0315	0.0327	CbGbCtD
Apixaban—CYP2C9—Dexamethasone—ankylosing spondylitis	0.0271	0.028	CbGbCtD
Apixaban—CYP3A4—Betamethasone—ankylosing spondylitis	0.0271	0.028	CbGbCtD
Apixaban—CYP3A4—Prednisolone—ankylosing spondylitis	0.0267	0.0276	CbGbCtD
Apixaban—ABCB1—Dexamethasone—ankylosing spondylitis	0.0263	0.0272	CbGbCtD
Apixaban—CYP3A4—Prednisone—ankylosing spondylitis	0.0252	0.0261	CbGbCtD
Apixaban—ABCB1—Methotrexate—ankylosing spondylitis	0.0211	0.0219	CbGbCtD
Apixaban—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0157	0.0163	CbGbCtD
Apixaban—Conjunctival haemorrhage—Dexamethasone—ankylosing spondylitis	0.00136	0.0395	CcSEcCtD
Apixaban—Conjunctival haemorrhage—Betamethasone—ankylosing spondylitis	0.00136	0.0395	CcSEcCtD
Apixaban—Petechiae—Prednisolone—ankylosing spondylitis	0.000646	0.0188	CcSEcCtD
Apixaban—Petechiae—Triamcinolone—ankylosing spondylitis	0.000594	0.0172	CcSEcCtD
Apixaban—Petechiae—Methylprednisolone—ankylosing spondylitis	0.000593	0.0172	CcSEcCtD
Apixaban—Petechiae—Dexamethasone—ankylosing spondylitis	0.000539	0.0156	CcSEcCtD
Apixaban—Petechiae—Betamethasone—ankylosing spondylitis	0.000539	0.0156	CcSEcCtD
Apixaban—Contusion—Dexamethasone—ankylosing spondylitis	0.000508	0.0148	CcSEcCtD
Apixaban—Contusion—Betamethasone—ankylosing spondylitis	0.000508	0.0148	CcSEcCtD
Apixaban—Ecchymosis—Prednisolone—ankylosing spondylitis	0.00048	0.0139	CcSEcCtD
Apixaban—Petechiae—Prednisone—ankylosing spondylitis	0.000469	0.0136	CcSEcCtD
Apixaban—Haematemesis—Methotrexate—ankylosing spondylitis	0.000464	0.0135	CcSEcCtD
Apixaban—Diabetes mellitus—Prednisolone—ankylosing spondylitis	0.000443	0.0129	CcSEcCtD
Apixaban—Contusion—Prednisone—ankylosing spondylitis	0.000443	0.0128	CcSEcCtD
Apixaban—Ecchymosis—Triamcinolone—ankylosing spondylitis	0.000442	0.0128	CcSEcCtD
Apixaban—Ecchymosis—Methylprednisolone—ankylosing spondylitis	0.000441	0.0128	CcSEcCtD
Apixaban—Diabetes mellitus—Triamcinolone—ankylosing spondylitis	0.000408	0.0118	CcSEcCtD
Apixaban—Diabetes mellitus—Methylprednisolone—ankylosing spondylitis	0.000407	0.0118	CcSEcCtD
Apixaban—Blood alkaline phosphatase increased—Methylprednisolone—ankylosing spondylitis	0.000407	0.0118	CcSEcCtD
Apixaban—Ecchymosis—Dexamethasone—ankylosing spondylitis	0.000401	0.0116	CcSEcCtD
Apixaban—Ecchymosis—Betamethasone—ankylosing spondylitis	0.000401	0.0116	CcSEcCtD
Apixaban—Petechiae—Methotrexate—ankylosing spondylitis	0.000392	0.0114	CcSEcCtD
Apixaban—Diabetes mellitus—Dexamethasone—ankylosing spondylitis	0.00037	0.0107	CcSEcCtD
Apixaban—Diabetes mellitus—Betamethasone—ankylosing spondylitis	0.00037	0.0107	CcSEcCtD
Apixaban—Ecchymosis—Prednisone—ankylosing spondylitis	0.000349	0.0101	CcSEcCtD
Apixaban—Diabetes mellitus—Prednisone—ankylosing spondylitis	0.000322	0.00936	CcSEcCtD
Apixaban—Breast disorder—Methylprednisolone—ankylosing spondylitis	0.00032	0.00929	CcSEcCtD
Apixaban—Melaena—Methotrexate—ankylosing spondylitis	0.000315	0.00915	CcSEcCtD
Apixaban—Alanine aminotransferase increased—Methylprednisolone—ankylosing spondylitis	0.000312	0.00906	CcSEcCtD
Apixaban—Ecchymosis—Methotrexate—ankylosing spondylitis	0.000292	0.00847	CcSEcCtD
Apixaban—Gastrointestinal haemorrhage—Prednisone—ankylosing spondylitis	0.00028	0.00814	CcSEcCtD
Apixaban—Diabetes mellitus—Methotrexate—ankylosing spondylitis	0.000269	0.00782	CcSEcCtD
Apixaban—Haemoglobin—Prednisolone—ankylosing spondylitis	0.000268	0.00779	CcSEcCtD
Apixaban—Haemorrhage—Prednisolone—ankylosing spondylitis	0.000267	0.00775	CcSEcCtD
Apixaban—Epistaxis—Triamcinolone—ankylosing spondylitis	0.000258	0.00749	CcSEcCtD
Apixaban—Alanine aminotransferase increased—Prednisone—ankylosing spondylitis	0.000247	0.00718	CcSEcCtD
Apixaban—Haemoglobin—Triamcinolone—ankylosing spondylitis	0.000247	0.00716	CcSEcCtD
Apixaban—Haemoglobin—Methylprednisolone—ankylosing spondylitis	0.000246	0.00715	CcSEcCtD
Apixaban—Haemorrhage—Triamcinolone—ankylosing spondylitis	0.000245	0.00712	CcSEcCtD
Apixaban—Haemorrhage—Methylprednisolone—ankylosing spondylitis	0.000245	0.00711	CcSEcCtD
Apixaban—Connective tissue disorder—Methylprednisolone—ankylosing spondylitis	0.000241	0.00699	CcSEcCtD
Apixaban—Eye disorder—Methylprednisolone—ankylosing spondylitis	0.000229	0.00664	CcSEcCtD
Apixaban—Haemoglobin—Betamethasone—ankylosing spondylitis	0.000224	0.0065	CcSEcCtD
Apixaban—Haemoglobin—Dexamethasone—ankylosing spondylitis	0.000224	0.0065	CcSEcCtD
Apixaban—Haemorrhage—Dexamethasone—ankylosing spondylitis	0.000223	0.00646	CcSEcCtD
Apixaban—Haemorrhage—Betamethasone—ankylosing spondylitis	0.000223	0.00646	CcSEcCtD
Apixaban—Angiopathy—Methylprednisolone—ankylosing spondylitis	0.000222	0.00645	CcSEcCtD
Apixaban—Immune system disorder—Methylprednisolone—ankylosing spondylitis	0.000221	0.00642	CcSEcCtD
Apixaban—Mediastinal disorder—Methylprednisolone—ankylosing spondylitis	0.000221	0.00641	CcSEcCtD
Apixaban—Liver function test abnormal—Methotrexate—ankylosing spondylitis	0.000216	0.00628	CcSEcCtD
Apixaban—Breast disorder—Methotrexate—ankylosing spondylitis	0.000212	0.00615	CcSEcCtD
Apixaban—Syncope—Prednisolone—ankylosing spondylitis	0.000208	0.00605	CcSEcCtD
Apixaban—Eye disorder—Betamethasone—ankylosing spondylitis	0.000208	0.00604	CcSEcCtD
Apixaban—Eye disorder—Dexamethasone—ankylosing spondylitis	0.000208	0.00604	CcSEcCtD
Apixaban—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.000204	0.00593	CcSEcCtD
Apixaban—Angiopathy—Dexamethasone—ankylosing spondylitis	0.000202	0.00587	CcSEcCtD
Apixaban—Angiopathy—Betamethasone—ankylosing spondylitis	0.000202	0.00587	CcSEcCtD
Apixaban—Haemoglobin—Prednisone—ankylosing spondylitis	0.000195	0.00566	CcSEcCtD
Apixaban—Haemorrhage—Prednisone—ankylosing spondylitis	0.000194	0.00563	CcSEcCtD
Apixaban—Syncope—Triamcinolone—ankylosing spondylitis	0.000192	0.00556	CcSEcCtD
Apixaban—Syncope—Methylprednisolone—ankylosing spondylitis	0.000191	0.00555	CcSEcCtD
Apixaban—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.000191	0.00553	CcSEcCtD
Apixaban—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.00019	0.0055	CcSEcCtD
Apixaban—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.000188	0.00545	CcSEcCtD
Apixaban—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.000187	0.00544	CcSEcCtD
Apixaban—Shock—Prednisolone—ankylosing spondylitis	0.000187	0.00542	CcSEcCtD
Apixaban—Eye disorder—Prednisone—ankylosing spondylitis	0.000181	0.00526	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.00018	0.00523	CcSEcCtD
Apixaban—Angiopathy—Prednisone—ankylosing spondylitis	0.000176	0.00511	CcSEcCtD
Apixaban—Immune system disorder—Prednisone—ankylosing spondylitis	0.000175	0.00509	CcSEcCtD
Apixaban—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000174	0.00506	CcSEcCtD
Apixaban—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000174	0.00505	CcSEcCtD
Apixaban—Syncope—Betamethasone—ankylosing spondylitis	0.000174	0.00505	CcSEcCtD
Apixaban—Syncope—Dexamethasone—ankylosing spondylitis	0.000174	0.00505	CcSEcCtD
Apixaban—Haematuria—Methotrexate—ankylosing spondylitis	0.000172	0.005	CcSEcCtD
Apixaban—Shock—Triamcinolone—ankylosing spondylitis	0.000172	0.00498	CcSEcCtD
Apixaban—Shock—Methylprednisolone—ankylosing spondylitis	0.000171	0.00497	CcSEcCtD
Apixaban—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000171	0.00496	CcSEcCtD
Apixaban—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000171	0.00495	CcSEcCtD
Apixaban—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.00017	0.00495	CcSEcCtD
Apixaban—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.00017	0.00495	CcSEcCtD
Apixaban—Epistaxis—Methotrexate—ankylosing spondylitis	0.00017	0.00494	CcSEcCtD
Apixaban—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000169	0.00491	CcSEcCtD
Apixaban—Haemoglobin—Methotrexate—ankylosing spondylitis	0.000163	0.00473	CcSEcCtD
Apixaban—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000163	0.00472	CcSEcCtD
Apixaban—Haemorrhage—Methotrexate—ankylosing spondylitis	0.000162	0.00471	CcSEcCtD
Apixaban—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.00016	0.00465	CcSEcCtD
Apixaban—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000159	0.00461	CcSEcCtD
Apixaban—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000158	0.00459	CcSEcCtD
Apixaban—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000158	0.00459	CcSEcCtD
Apixaban—Anaemia—Prednisone—ankylosing spondylitis	0.000156	0.00453	CcSEcCtD
Apixaban—Shock—Dexamethasone—ankylosing spondylitis	0.000156	0.00452	CcSEcCtD
Apixaban—Shock—Betamethasone—ankylosing spondylitis	0.000156	0.00452	CcSEcCtD
Apixaban—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000155	0.0045	CcSEcCtD
Apixaban—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000155	0.0045	CcSEcCtD
Apixaban—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000155	0.0045	CcSEcCtD
Apixaban—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000155	0.0045	CcSEcCtD
Apixaban—Eye disorder—Methotrexate—ankylosing spondylitis	0.000151	0.0044	CcSEcCtD
Apixaban—Syncope—Prednisone—ankylosing spondylitis	0.000151	0.0044	CcSEcCtD
Apixaban—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000148	0.00431	CcSEcCtD
Apixaban—Hypotension—Dexamethasone—ankylosing spondylitis	0.000148	0.00429	CcSEcCtD
Apixaban—Hypotension—Betamethasone—ankylosing spondylitis	0.000148	0.00429	CcSEcCtD
Apixaban—Angiopathy—Methotrexate—ankylosing spondylitis	0.000147	0.00427	CcSEcCtD
Apixaban—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000146	0.00425	CcSEcCtD
Apixaban—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000146	0.00424	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000143	0.00414	CcSEcCtD
Apixaban—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00014	0.00406	CcSEcCtD
Apixaban—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000138	0.004	CcSEcCtD
Apixaban—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000137	0.00397	CcSEcCtD
Apixaban—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000137	0.00397	CcSEcCtD
Apixaban—Shock—Prednisone—ankylosing spondylitis	0.000136	0.00394	CcSEcCtD
Apixaban—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000135	0.00392	CcSEcCtD
Apixaban—Skin disorder—Prednisone—ankylosing spondylitis	0.000134	0.00389	CcSEcCtD
Apixaban—Anaemia—Methotrexate—ankylosing spondylitis	0.00013	0.00379	CcSEcCtD
Apixaban—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000128	0.00373	CcSEcCtD
Apixaban—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000128	0.00372	CcSEcCtD
Apixaban—Dizziness—Prednisolone—ankylosing spondylitis	0.000125	0.00364	CcSEcCtD
Apixaban—Rash—Prednisolone—ankylosing spondylitis	0.00012	0.00347	CcSEcCtD
Apixaban—Dermatitis—Prednisolone—ankylosing spondylitis	0.000119	0.00347	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000119	0.00346	CcSEcCtD
Apixaban—Dizziness—Triamcinolone—ankylosing spondylitis	0.000115	0.00335	CcSEcCtD
Apixaban—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000115	0.00334	CcSEcCtD
Apixaban—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000115	0.00334	CcSEcCtD
Apixaban—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000113	0.00328	CcSEcCtD
Apixaban—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000113	0.00327	CcSEcCtD
Apixaban—Nausea—Prednisolone—ankylosing spondylitis	0.000113	0.00327	CcSEcCtD
Apixaban—Skin disorder—Methotrexate—ankylosing spondylitis	0.000112	0.00325	CcSEcCtD
Apixaban—Rash—Triamcinolone—ankylosing spondylitis	0.00011	0.00319	CcSEcCtD
Apixaban—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00011	0.00319	CcSEcCtD
Apixaban—Rash—Methylprednisolone—ankylosing spondylitis	0.00011	0.00318	CcSEcCtD
Apixaban—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00011	0.00318	CcSEcCtD
Apixaban—Hypotension—Methotrexate—ankylosing spondylitis	0.000108	0.00312	CcSEcCtD
Apixaban—Dizziness—Betamethasone—ankylosing spondylitis	0.000105	0.00304	CcSEcCtD
Apixaban—Dizziness—Dexamethasone—ankylosing spondylitis	0.000105	0.00304	CcSEcCtD
Apixaban—Nausea—Triamcinolone—ankylosing spondylitis	0.000104	0.00301	CcSEcCtD
Apixaban—Nausea—Methylprednisolone—ankylosing spondylitis	0.000103	0.003	CcSEcCtD
Apixaban—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000101	0.00295	CcSEcCtD
Apixaban—Rash—Dexamethasone—ankylosing spondylitis	9.97e-05	0.0029	CcSEcCtD
Apixaban—Rash—Betamethasone—ankylosing spondylitis	9.97e-05	0.0029	CcSEcCtD
Apixaban—Dermatitis—Dexamethasone—ankylosing spondylitis	9.96e-05	0.00289	CcSEcCtD
Apixaban—Dermatitis—Betamethasone—ankylosing spondylitis	9.96e-05	0.00289	CcSEcCtD
Apixaban—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	9.94e-05	0.00289	CcSEcCtD
Apixaban—Nausea—Dexamethasone—ankylosing spondylitis	9.4e-05	0.00273	CcSEcCtD
Apixaban—Nausea—Betamethasone—ankylosing spondylitis	9.4e-05	0.00273	CcSEcCtD
Apixaban—Dizziness—Prednisone—ankylosing spondylitis	9.11e-05	0.00265	CcSEcCtD
Apixaban—Rash—Prednisone—ankylosing spondylitis	8.69e-05	0.00252	CcSEcCtD
Apixaban—Dermatitis—Prednisone—ankylosing spondylitis	8.68e-05	0.00252	CcSEcCtD
Apixaban—Hypersensitivity—Methotrexate—ankylosing spondylitis	8.48e-05	0.00246	CcSEcCtD
Apixaban—Nausea—Prednisone—ankylosing spondylitis	8.18e-05	0.00238	CcSEcCtD
Apixaban—Dizziness—Methotrexate—ankylosing spondylitis	7.61e-05	0.00221	CcSEcCtD
Apixaban—Rash—Methotrexate—ankylosing spondylitis	7.26e-05	0.00211	CcSEcCtD
Apixaban—Dermatitis—Methotrexate—ankylosing spondylitis	7.25e-05	0.00211	CcSEcCtD
Apixaban—Nausea—Methotrexate—ankylosing spondylitis	6.84e-05	0.00199	CcSEcCtD
